<unk> es are a small group of inherited disorders that result from defects in creatine biosynthesis and utilization. Commonly affected tissues include the brain and muscles. There are three distinct CCDs. The most common is creatine transporter defect (CTD), an X-linked disorder caused by pathogenic variants in SLC6A8. The main symptoms of CTD are intellectual disability and developmental delay, and these are caused by a lack of creatine in the brain, due to the defective transporter. There are also two enzymatic defects of creatine biosynthesis, arginine:glycine amidinotransferase<unk>  (AGAT<unk> , caused by variants in GATM and guanidinoacetate methyltransferase<unk>  (GAMT<unk> , caused by variants in GAMT. The single enzyme defects are both inherited in an autosomal recessive manner. Creatine is synthesized in the kidney and liver, by a two step enzymatic process. In the first step, glycine and arginine are combined by arginine:glycine amidinotransferase to form guanidinoacetate. This step also results in the production of ornithine. Creatine is produced by the enzyme guanidinoacetate methyltransferase. After production in the liver and kidneys, creatine is transported to organs and tissues with high energy demands, most commonly the brain and skeletal muscles. In addition to endogenous production, creatine can be obtained from dietary sources or supplementation. Ornithine aminotransferase<unk>  can cause secondary creatine<unk> , however it does not result in<unk> . __TOC__
Cerebral creatine deficiency
Pantothenate kinase-associated neurodegeneration
Creatine transporter defect
N-Acetylglutamate synthase deficiency
Dopamine beta hydroxylase deficiency
Systemic primary carnitine deficiency
Mitochondrial encephalomyopathy
Mitochondrial toxicity